Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | CA5A | P35218 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CFTR | P13569 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ALPG | P10696 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triphenylphosphine Oxide SCHEMBL3949 | 1.00 | CA2 (0.58) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL3753871 | 0.97 | CA2 (0.55) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL8431251 | 0.97 | CA2 (0.63) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL14471889 | 0.97 | CA2 (0.55) | CA2CA4CA5ALMNACFTR | |
| SCHEMBL5439069 | 0.97 | LMNA (0.60) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL7991003 | 0.97 | CA2 (0.55) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL7551485 | 0.97 | CA2 (0.55) | CA2CA4CA5ALMNACFTR | |
| SCHEMBL132983 | 0.97 | LMNA (0.60) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL9425396 | 0.97 | CA2 (0.55) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL11214761 | 0.97 | CA2 (0.55) | CA2CA4CA5ALMNACFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115260233-A | Imidazole type fluorescent molecule containing triphenylphosphine oxide structure, preparation method thereof and application of imidazole type fluorescent molecule as fluorescent probe | 江西师范大学 | 2022-11-01 | — | — | CN | claimed |
| CN-114213314-A | Organic electroluminescent material based on carbazole-9-yl-diphenylamine derivatives and electronic device thereof | 维思普新材料（苏州）有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-111620820-A | Pyridofluorene derivative, synthesis method thereof and electronic device thereof | 苏州久显新材料有限公司 | 2020-09-04 | — | — | CN | claimed |
| CN-111606906-A | Polycyclic nitrogen-containing compound and electronic device | 苏州久显新材料有限公司 | 2020-09-01 | — | — | CN | claimed |
| CN-111393424-A | Fluoresenotrianiline compound, organic electronic device, and display device or lighting device | 苏州大学 | 2020-07-10 | — | — | CN | claimed |
| CN-110423297-A | Asymmetric transition-metal catalyst of a kind of [C^N^O] three tooth chelating and preparation method thereof | UNIV NANCHANG | 2019-11-08 | — | — | CN | claimed |
| CN-108148038-B | Three allyloxy dibenzo [b, f] dislike English in heptan cyclopropylene ester type compound and intermediate and its application | JIANG University OF TECHNOLOGY (CN) | 2019-10-29 | — | — | CN | claimed |
| CN-110218225-A | The preparation method of ligand, nickel complex and polyolefin compound | 中国科学技术大学 | 2019-09-10 | — | — | CN | claimed |
| CN-109867654-A | A method of alkylene carbonates are prepared for epoxyalkane and carbon dioxide | 山东石大胜华化工集团股份有限公司 | 2019-06-11 | — | — | CN | claimed |
| CN-106554301-B | A kind of preparation method of saxagliptin key intermediate | 深圳翰宇药业股份有限公司 | 2018-09-21 | — | — | CN | claimed |
| CN-102136314-A | Preparation method of composite microspheres, anisotropy conducting material and anisotropy conducting film | SUZHOU NANO MICRO BIO TECH CO LTD | 2011-07-27 | — | — | CN | claimed |
| US-7718803-B2 | Self-dispersible bipyridine-based metal complex and ink composition comprising the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-05-18 | — | — | US | claimed |
| CN-100528868-C | Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives | NOVARTIS AG (CH) | 2009-08-19 | — | — | CN | claimed |
| CN-100481563-C | White light-emitting organic electroluminescent devices | GEN ELECTRIC (US) | 2009-04-22 | — | — | CN | claimed |
| US-20050033040-A1 | Self-dispersible bipyridine-based metal complex and ink composition comprising the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-02-10 | — | — | US | claimed |
| CN-1520237-A | White light-emitting organic electroluminescent devices | ͨ�õ�����˾ | 2004-08-11 | — | — | CN | claimed |
| CN-1104450-C | Homopolymers and copolymers of cationically polymerizable monomers and process for their preparation | GOODRICH CO B F (US) | 2003-04-02 | — | — | CN | claimed |
| CN-1308614-A | Benzimidazoles, production thereof and use thereof medicaments | BOEHRINGER INGELHEIM PHAMA KG (DE) | 2001-08-15 | — | — | CN | claimed |
| US-4981984-A | LANGMUIR BLODGETT PYROELECTRIC RUTHENIUM-PHOSPHINE-NITRILE FILM | THORN EMI PLC (GB) | 1991-01-01 | — | — | US | claimed |
| EP-0301725-A2 | Organo metallic compounds of ruthenium iron or cobalt and their use | THORN EMI plc (GB) | 1989-02-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050033040-A1 | Self-dispersible bipyridine-based metal complex and ink composition comprising the same | PDCD2L, BICRA, BRD1 | CA2 3624/4885CA4 4237/4885CA5A 4246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.